Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459179) titled 'Clinical Study on the Application of PET Probes Targeting DDR2 in the Diagnosis of Interstitial Lung Disease With Cognitive Impairment' on March 4.

Study Type: Observational

Primary Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Condition: Interstitial Lung Disease

Recruitment Status: Not recruiting

Date of First Enrollment: April 1, 2026

Target Sample Size: 50

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07459179

Published by HT Digital Content Services with permission from Health Daily Digest....